Single Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HSD-016
Clinical trial NCT00739232 · COMPLETED
Trial details
- NCT number
- NCT00739232
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2009-02-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.